Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca gets right to commercialize Eplontersen in Latin America

Ruchika Sharma1 Aug 2023 1:30 PM IST

AstraZeneca paid Ionis USD 20 million to license eplontersen in Latin America.

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Janssen seeks USFDA nod for expanded pediatric indication for HIV-1 therapy Edurant

Ruchika Sharma1 Aug 2023 12:32 PM IST

Titusville: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA)...

GSK gets USFDA nod for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Ruchika Sharma1 Aug 2023 11:30 AM IST

Jemperli is already approved in the US as monotherapy in adult patients with dMMR recurrent or advanced endometrial cancer that has progressed on or...

Venus Remedies secures marketing authorisation for key cancer drugs from Philippines, Paraguay, Georgia and Moldova

Ruchika Sharma31 July 2023 4:30 PM IST

Bangalore: Building up on its sizeable global presence in the oncology space, Venus Remedies Ltd, a well-known provider of affordable cancer drugs...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson and Johnson effort to resolve talc lawsuits in bankruptcy fails second time

Ruchika Sharma31 July 2023 3:30 PM IST

US: A U.S. judge on Friday shot down Johnson & Johnson's second attempt to resolve tens of thousands of lawsuits over its talc products in...

Novo Nordisk launches weight-loss drug Wegovy in Germany

Ruchika Sharma31 July 2023 2:30 PM IST

Doctors say many Germans seeking to lose weight have already used Ozempic, a diabetes drug also made by Novo that is a lower dose version of the same...

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

Sun Pharma eyes high single-digit revenue growth in FY24

Ruchika Sharma31 July 2023 1:30 PM IST

The drug maker is currently sitting on a net cash position of around USD 1.5 billion, Shanghvi said.

Alembic Pharma, Sun Pharma recall drugs in US over manufacturing issues

Ruchika Sharma31 July 2023 12:30 PM IST

The US Health regulator stated that Alembic Pharmaceuticals is recalling 2,844 units of Diclofenac Sodium Topical Solution in the American market.

Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution

USFDA concludes inspection at Gland Pharma Visakhapatnam facility with zero 483 observations

Ruchika Sharma31 July 2023 11:27 AM IST

Telangana: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice...

AstraZeneca Rare Disease arm enters agreement with Pfizer to acquire portfolio of preclinical rare disease gene therapies

Ruchika Sharma30 July 2023 3:30 PM IST

Under the agreement, Alexion will purchase and licence the assets of Pfizer's early-stage rare disease gene therapy portfolio for a total...

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon Foundation releases second edition of Consensus Guidelines for Head and Neck Cancer

Ruchika Sharma30 July 2023 3:30 PM IST

Bengaluru: Biocon Foundation, the Corporate Social Responsibility (CSR) arm of the Biocon Group, held its annual Oral Cancer Task Force Conference...

India has become Pharmacy of World, now it is time for India to become Factory of World: Dr Mansukh Mandaviya

Ruchika Sharma30 July 2023 12:00 PM IST

Dr Mandaviya further invited suggestions which will drive innovative and sustainable solutions for positive change and progress in this sector.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok